Literature DB >> 10513988

Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements.

D Schmid1, G Ecker, S Kopp, M Hitzler, P Chiba.   

Abstract

Propafenone analogs (PAs) were previously identified as potent inhibitors of P-glycoprotein (Pgp)-mediated toxin efflux. For this as well as other classes of Pgp inhibitors, lipophilicity as well as hydrogen bond acceptor strength are important determinants of biological activity. The question as to whether a direct interaction between PA-type modulators and Pgp takes place was addressed by means of Pgp ATPase measurements and transport studies. Propafenone-type modulators stimulated ATPase activity up to 2-fold over basal activity in a concentration-dependent biphasic manner. Within a series of structural homologs, Ka values of ATPase stimulation strongly correlated with lipophilicity. Analogs containing a quaternary nitrogen stimulated Pgp ATPase activity with lesser efficacy, while Ka values were somewhat higher when compared to corresponding tertiary analogs. Transport studies performed in inside-out plasma membrane (I/O) vesicles demonstrated that analogs containing a tertiary nitrogen rapidly associated with the biomembrane. Quaternary analogs, which are restricted by a permanent positive charge in transiting the plasma membrane by diffusion, accumulated in Pgp containing I/O vesicles in an ATP-dependent and cyclosporin A-inhibitable manner, which identified them as Pgp substrates. Identical structure-activity relationships were found in either Pgp ATPase stimulation experiments in I/O vesicles or in toxin efflux inhibition studies using intact cells. Therefore, differences in membrane transit are not responsible for the observed structure-activity relationships.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10513988     DOI: 10.1016/s0006-2952(99)00229-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  MCASE study of the multidrug resistance reversal activity of propafenone analogs.

Authors:  Gilles Klopman; Hao Zhu; Gerhard Ecker; Peter Chiba
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

2.  Molecular dissection of dual pseudosymmetric solute translocation pathways in human P-glycoprotein.

Authors:  Zahida Parveen; Thomas Stockner; Caterina Bentele; Sandra Pferschy; Martin Kraupp; Michael Freissmuth; Gerhard F Ecker; Peter Chiba
Journal:  Mol Pharmacol       Date:  2010-12-21       Impact factor: 4.436

Review 3.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

4.  Molecular Mechanism of Taurocholate Transport by the Bile Salt Export Pump, an ABC Transporter Associated with Intrahepatic Cholestasis.

Authors:  Muhammad Imran Sohail; Diethart Schmid; Katrin Wlcek; Matthias Spork; Gergely Szakács; Michael Trauner; Thomas Stockner; Peter Chiba
Journal:  Mol Pharmacol       Date:  2017-08-07       Impact factor: 4.436

Review 5.  Application of pharmacological approaches to plant-mammal interactions.

Authors:  Jennifer S Sorensen; Michele M Skopec; M Denise Dearing
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

6.  Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein.

Authors:  Iouri Bachmakov; Sabine Rekersbrink; Ute Hofmann; Michel Eichelbaum; Martin F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-15       Impact factor: 3.000

7.  Similarity based SAR (SIBAR) as tool for early ADME profiling.

Authors:  Christian Klein; Dominik Kaiser; Stephan Kopp; Peter Chiba; Gerhard F Ecker
Journal:  J Comput Aided Mol Des       Date:  2002-11       Impact factor: 3.686

Review 8.  The complexities of hepatic drug transport: current knowledge and emerging concepts.

Authors:  Priyamvada Chandra; Kim L R Brouwer
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.580

9.  Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).

Authors:  P Heffeter; M A Jakupec; W Körner; P Chiba; C Pirker; R Dornetshuber; L Elbling; H Sutterlüty; M Micksche; B K Keppler; W Berger
Journal:  Biochem Pharmacol       Date:  2007-03-12       Impact factor: 5.858

10.  Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs.

Authors:  Yaprak Dönmez Cakil; Narakorn Khunweeraphong; Zahida Parveen; Diethart Schmid; Matthias Artaker; Gerhard F Ecker; Harald H Sitte; Oliver Pusch; Thomas Stockner; Peter Chiba
Journal:  Mol Pharmacol       Date:  2013-12-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.